UCB - Umsatzkosten





Umsatzkosten Veränderung Datum
Alcon AG USD 1.18B 26M 2026-03
Almirall EUR 199.26M 7.76M 2026-06
Amarin USD 26.05M 1.41M 2025-12
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 5.23B 731M 2026-03
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Orion EUR 181.7M 18M 2026-06
Recordati EUR 202.6M 13.03M 2026-03
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12
Unibail Rodamco EUR 546.4M 9.4M 2025-12